Established in 1985, we offer a broad portfolio of 185 generic pharmaceutical products, mainly in the form of tablets, capsules and injections. Our portfolio includes a growing range of specialist oncology products and product formulations, predominantly solid oral dosages.

Tableti, iPad računari, tableti za decu, šta god da vam treba, Tehnomedia je tu za vas. Posetite nas i odaberite uređaj koji želite ili poručite online!

Medis je slovensko podjetje za trženje inovativnih zdravil, sodobnih medicinskih pripomočkov ter izdelkov brez recepta. V državah srednje in vzhodne Evrope skrbimo, da so najsodobnejši načini zdravljenja na voljo vsem, ki jih potrebujejo.

Tablet fiyatları genellikle teknik özelliklere, malzeme kalitesine ve ek yazılım avantajlarına göre değişiklik gösterir. Bu nedenle bir cihazı seçmeden önce hem fiyatını hem de uzun vadede sağlayacağı faydaları değerlendirmek gerekir. Böyle bir yaklaşım hem ekonomik hem de işlevsel bir seçim yapmanıza yardımcı olabilir.

Medis offers a broad portfolio of 185+ pharmaceutical products covering a broad range of therapeutic areas. We offer multiple dosage forms including immediate and modified release tablets and capsules, soft gel capsules, nasal suspensions, …

Our comprehensive portfolio currently includes about 185 pharmaceutical products covering a broad range of therapeutic areas. We offer a wide range of dosage forms including immediate and modified release tablets and capsules, soluble and oro-dispersible tablets, soft gel capsules, nasal suspensions, ointments, gels, oral liquids and injectables.

Medis’s innovations address their needs by carefully selecting the best, most innovative ingredients and processes. We insist upon quality and vitality in our daily practise, so we take the best possible care not only of our patients, but also for the natural world around us. We are proud of our health brands’ success.

We strive to improve people’s health by providing novel treatments in Central and Eastern Europe. We are the commercialization partner of choice for innovative pharmaceutical and biotech companies seeking business growth in Europe. Our wholly-owned subsidiaries operate in 18 countries in Central and Eastern Europe.

Product type: Capsule, hard , Dosage: 100mg, 300mg, 400mg

Medis Consumer Health R&D Initiatives. As a dynamically evolving team we are proud of our unique medicinal products, which are the result of our own research and development and aligned with the latest health trends. As of 2021, both OTC medicines are approved in more than 20 European countries, with plans to expand in the future.